Showing results (111-120 of 221) with videos related to
Sort By:
Pageof 23
Nature Microbiology|April 1, 2026
Chikungunya virus persists in joint-associated macrophages and promotes chronic disease in miceKristen M Zarrella, Ryan M Sheridan, Brian C Ware, et al.Vaccines|April 23, 2022
Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease SeverityAlba Grifoni, Hannah Voic, Esther Dawen Yu, et al.Biorxiv : the Preprint Server for Biology|March 10, 2021
Negligible impact of SARS-CoV-2 variants on CD4 <sup>+</sup> and CD8 <sup>+</sup> T cell reactivity in COVID-19 exposed donors and vaccineesAlison Tarke, John Sidney, Nils Methot, et al.Nature Communications|July 1, 2025
Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4<sup>+</sup> T cells in chronic chikungunya diseaseRimjhim Agarwal, Calvin Ha, Fernanda H Côrtes, et al.Cell|June 28, 2022
Humoral and cellular immune memory to four COVID-19 vaccinesZeli Zhang, Jose Mateus, Camila H Coelho, et al.Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2013
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cellsDaniela Weiskopf, Michael A Angelo, Elzinandes L de Azeredo, et al.Vaccine|February 12, 2025
Impact in the humoral and cellular immune response to SARS-CoV-2 variants after primary vaccination with AZD1222/COVISHIELD protocol in healthy adultsArtur Capão, Mia Ferreira Araújo, Luis Fernando Lopez Tort, et al.JCI Insight|September 4, 2025
Pediatric T cell and B cell responses to SARS-CoV-2 infectionL Benjamin Hills, Numana Bhat, Jillian H Hurst, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 8, 2023
Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infectionIvan Ssali, Susan Mugaba, Arthur Kalyebi Watelo, et al.Pageof 23